Fulgent Genetics

Yahoo Finance • 25 days ago

FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT) investors concerning the Company’s and/or... Full story

Yahoo Finance • 28 days ago

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) for potential... Full story

Yahoo Finance • last month

Catalyst Watch: Eyes on oil prices, inflation reads, and Oracle earnings

[manhattan office building] franckreporter/iStock via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices ne... Full story

Yahoo Finance • last month

Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). The investigation focuses on Fulgent’s executive officers and whether i... Full story

Yahoo Finance • last month

Top Midday Decliners

Fulgent Genetics (FLGT) reported Friday Q4 sales below market expectations, and its forecasts for no PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 months ago

Fulgent Genetics Non-GAAP EPS of $0.14 beats by $0.36, revenue of $84.07M beats by $2.64M

* Fulgent Genetics press release [https://seekingalpha.com/pr/20298686-fulgent-reports-third-quarter-2025-financial-results] (FLGT [https://seekingalpha.com/symbol/FLGT]): Q3 Non-GAAP EPS of $0.14 beats by $0.36. * Revenue of $84.07M (... Full story

Yahoo Finance • 9 months ago

Fulgent Genetics gets EU approval for germline sequencing system

[COVID-19 - laboratory team working on coronavirus vaccine. Protective workwear] janiecbros/E+ via Getty Images * Fulgent Genetics (NASDAQ:FLGT [https://seekingalpha.com/symbol/FLGT]) has received European Union’s CE certification for i... Full story

Yahoo Finance • 9 months ago

Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR), GoHealth (GOCO), Adtran (ADTN), or Fulgent (FLGT) To Contact Him Directly To Discuss Their Options If you purchased o... Full story

Yahoo Finance • 9 months ago

Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO), Semler Scientific Inc. (NASDAQ:SMLR), F... Full story

Yahoo Finance • 10 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT).  Such investors are advised to contact Danielle Peyton at ne... Full story

Yahoo Finance • 10 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT).  Such investors are advised to contact Danielle Peyton at ne... Full story

Yahoo Finance • 10 months ago

Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Semler Scientific Inc. (NASDAQ:SMLR), ADTRAN Holdings, Inc. (NASDAQ:A... Full story

Yahoo Finance • 10 months ago

Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against EchoStar Corporation (NASDAQ:SATS), Semler Scientific Inc. (NASDAQ:SM... Full story

Yahoo Finance • 11 months ago

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Fulgent Genetics, Inc. (NASDAQ: FLGT) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

NEWTOWN, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT), resulting from allegations of providing... Full story

Yahoo Finance • 11 months ago

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) on... Full story

Yahoo Finance • 11 months ago

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it... Full story

Yahoo Finance • 2 years ago

4 Stocks With Big Rebound Potential

A Wall Street adage warns, Don't try to catch a falling knife. I do it frequently. Buying good stocks on bad news is a sound methodology, I believe. You may not catch the exact bottom, but you're likely to find a good entry point. Each... Full story

Yahoo Finance • 2 years ago

Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting

EL MONTE, Calif., November 03, 2023--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development busines... Full story

Yahoo Finance • 2 years ago

Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results

Fulgent Genetics Inc (NASDAQ:FLGT) reports Q3 2023 total revenue of $85 million, with core revenue growing 17% YoY to $66 million. The company records a GAAP loss of $13.1 million, or $0.44 per share, and a non-GAAP loss of $11.7 million,... Full story

Yahoo Finance • 3 years ago

10 DNA Stocks Billionaires Are Loading Up On

In this article, we discuss 10 DNA stocks that billionaires love. If you want to skip our detailed analysis of the DNA market, head over to 5 DNA Stocks Billionaires Are Loading Up On. Genomics is the study of a complete set of DNA within... Full story